About this data
What it is
Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
Who files it
The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
How current
We collect new notices throughout the day on SEC business days.
Terms
Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
Worth knowing
A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.

All of this comes from public filings.

Form 144 notices per day, last 30 days

0100200300Oct 17 · All notices: 0Oct 17 · Notices that give a 10b5-1 plan: 0Oct 17Oct 18 · All notices: 0Oct 18 · Notices that give a 10b5-1 plan: 0Oct 19 · All notices: 47Oct 19 · Notices that give a 10b5-1 plan: 29Oct 20 · All notices: 52Oct 20 · Notices that give a 10b5-1 plan: 39Oct 21 · All notices: 46Oct 21 · Notices that give a 10b5-1 plan: 26Oct 21Oct 22 · All notices: 49Oct 22 · Notices that give a 10b5-1 plan: 22Oct 23 · All notices: 62Oct 23 · Notices that give a 10b5-1 plan: 23Oct 24 · All notices: 0Oct 24 · Notices that give a 10b5-1 plan: 0Oct 25 · All notices: 0Oct 25 · Notices that give a 10b5-1 plan: 0Oct 25Oct 26 · All notices: 75Oct 26 · Notices that give a 10b5-1 plan: 28Oct 27 · All notices: 71Oct 27 · Notices that give a 10b5-1 plan: 18Oct 28 · All notices: 54Oct 28 · Notices that give a 10b5-1 plan: 17Oct 29 · All notices: 100Oct 29 · Notices that give a 10b5-1 plan: 31Oct 29Oct 30 · All notices: 97Oct 30 · Notices that give a 10b5-1 plan: 35Oct 31 · All notices: 0Oct 31 · Notices that give a 10b5-1 plan: 0Nov 1 · All notices: 0Nov 1 · Notices that give a 10b5-1 plan: 0Nov 2 · All notices: 272Nov 2 · Notices that give a 10b5-1 plan: 133Nov 2Nov 3 · All notices: 142Nov 3 · Notices that give a 10b5-1 plan: 48Nov 4 · All notices: 190Nov 4 · Notices that give a 10b5-1 plan: 77Nov 5 · All notices: 148Nov 5 · Notices that give a 10b5-1 plan: 53Nov 6 · All notices: 127Nov 6 · Notices that give a 10b5-1 plan: 41Nov 6Nov 7 · All notices: 0Nov 7 · Notices that give a 10b5-1 plan: 0Nov 8 · All notices: 0Nov 8 · Notices that give a 10b5-1 plan: 0Nov 9 · All notices: 217Nov 9 · Notices that give a 10b5-1 plan: 75Nov 10 · All notices: 202Nov 10 · Notices that give a 10b5-1 plan: 59Nov 10Nov 11 · All notices: 0Nov 11 · Notices that give a 10b5-1 plan: 0Nov 12 · All notices: 240Nov 12 · Notices that give a 10b5-1 plan: 77Nov 13 · All notices: 127Nov 13 · Notices that give a 10b5-1 plan: 28Nov 14 · All notices: 0Nov 14 · Notices that give a 10b5-1 plan: 0Nov 14Nov 15 · All notices: 0Nov 15 · Notices that give a 10b5-1 plan: 0
0100200300Oct 17 · All notices: 0Oct 17 · Notices that give a 10b5-1 plan: 0Oct 17Oct 18 · All notices: 0Oct 18 · Notices that give a 10b5-1 plan: 0Oct 19 · All notices: 47Oct 19 · Notices that give a 10b5-1 plan: 29Oct 20 · All notices: 52Oct 20 · Notices that give a 10b5-1 plan: 39Oct 21 · All notices: 46Oct 21 · Notices that give a 10b5-1 plan: 26Oct 21Oct 22 · All notices: 49Oct 22 · Notices that give a 10b5-1 plan: 22Oct 23 · All notices: 62Oct 23 · Notices that give a 10b5-1 plan: 23Oct 24 · All notices: 0Oct 24 · Notices that give a 10b5-1 plan: 0Oct 25 · All notices: 0Oct 25 · Notices that give a 10b5-1 plan: 0Oct 25Oct 26 · All notices: 75Oct 26 · Notices that give a 10b5-1 plan: 28Oct 27 · All notices: 71Oct 27 · Notices that give a 10b5-1 plan: 18Oct 28 · All notices: 54Oct 28 · Notices that give a 10b5-1 plan: 17Oct 29 · All notices: 100Oct 29 · Notices that give a 10b5-1 plan: 31Oct 29Oct 30 · All notices: 97Oct 30 · Notices that give a 10b5-1 plan: 35Oct 31 · All notices: 0Oct 31 · Notices that give a 10b5-1 plan: 0Nov 1 · All notices: 0Nov 1 · Notices that give a 10b5-1 plan: 0Nov 2 · All notices: 272Nov 2 · Notices that give a 10b5-1 plan: 133Nov 2Nov 3 · All notices: 142Nov 3 · Notices that give a 10b5-1 plan: 48Nov 4 · All notices: 190Nov 4 · Notices that give a 10b5-1 plan: 77Nov 5 · All notices: 148Nov 5 · Notices that give a 10b5-1 plan: 53Nov 6 · All notices: 127Nov 6 · Notices that give a 10b5-1 plan: 41Nov 6Nov 7 · All notices: 0Nov 7 · Notices that give a 10b5-1 plan: 0Nov 8 · All notices: 0Nov 8 · Notices that give a 10b5-1 plan: 0Nov 9 · All notices: 217Nov 9 · Notices that give a 10b5-1 plan: 75Nov 10 · All notices: 202Nov 10 · Notices that give a 10b5-1 plan: 59Nov 10Nov 11 · All notices: 0Nov 11 · Notices that give a 10b5-1 plan: 0Nov 12 · All notices: 240Nov 12 · Notices that give a 10b5-1 plan: 77Nov 13 · All notices: 127Nov 13 · Notices that give a 10b5-1 plan: 28Nov 14 · All notices: 0Nov 14 · Notices that give a 10b5-1 plan: 0Nov 14Nov 15 · All notices: 0Nov 15 · Notices that give a 10b5-1 plan: 0

All notices Notices that give a 10b5-1 plan

By the day each notice was filed. A notice is a plan to sell, not a sale.

Latest notices of planned insider sales

Reset

Showing: ticker ARWR

Latest notices of planned insider sales
FiledInsiderCompanyShares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file.ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for.PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.Expected saleSale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have.Notice
Aug 18, 2026Adeoye Olukotun
Director
ARWR
Arrowhead Pharmaceuticals, Inc.
2,000$173.9K—Aug 18, 2026Form 4 ↗
2 days later · 2,000 shares
Form 144 ↗
Aug 18, 2026Michael Perry
Director
ARWR
Arrowhead Pharmaceuticals, Inc.
11,600$1.0M—Aug 18, 2026Form 4 ↗
2 days later · 11,600 shares
Form 144 ↗
May 19, 2026
amended
Daniel Apel
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
13,095$934.2K10b5-1Apr 22, 2026—Form 144/A ↗
May 19, 2026
amended
Hongbo Lu
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
2,970$228.3K10b5-1May 12, 2026—Form 144/A ↗
May 19, 2026
amended
James Hamilton
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
10,000$750.0K10b5-1Apr 23, 2026—Form 144/A ↗
May 12, 2026Hongbo Lu
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
2,970$228.3K—May 12, 2026Form 4 ↗
2 days later · 2,970 shares
Form 144 ↗
Apr 23, 2026James Hamilton
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
10,000$750.0K—Apr 23, 2026Form 4 ↗
1 day later · 10,000 shares
Form 144 ↗
Apr 22, 2026Daniel Apel
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
13,095$934.2K—Apr 22, 2026Form 4 ↗
2 days later · 13,095 shares
Form 144 ↗
Mar 5, 2026James Hamilton
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
10,000$641.9K10b5-1Mar 5, 2026Form 4 ↗
4 days later · 10,000 shares
Form 144 ↗
Jan 5, 2026
amended
James Hamilton
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
40,164$2.5M10b5-1Jan 5, 2026Form 4 ↗
same day · 40,164 shares
Form 144/A ↗
Jan 5, 2026James Hamilton
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
39,728$2.5M10b5-1Jan 5, 2026Form 4 ↗
same day · 40,164 shares
Form 144 ↗
Jan 5, 2026Patrick O'Brien
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
49,493$3.1M10b5-1Jan 5, 2026Form 4 ↗
same day · 49,493 shares
Form 144 ↗
Jan 2, 2026Christopher Anzalone
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
13,187$871.7K10b5-1Jan 2, 2026Form 4 ↗
3 days later · 13,187 shares
Form 144 ↗
Dec 29, 2025Christopher Anzalone
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
51,726$3.6M10b5-1Dec 29, 2025Form 4 ↗
1 day later · 51,726 shares
Form 144 ↗
Dec 29, 2025Mauro Ferrari
Director
ARWR
Arrowhead Pharmaceuticals, Inc.
7,530$527.1K10b5-1Dec 26, 2025Form 4 ↗
1 day later · 7,530 shares
Form 144 ↗
Dec 22, 2025Christopher Anzalone
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
12,586$861.3K10b5-1Dec 22, 2025Form 4 ↗
1 day later · 26,031 shares
Form 144 ↗
Dec 19, 2025Christopher Anzalone
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
13,445$909.6K10b5-1Dec 19, 2025Form 4 ↗
4 days later · 26,031 shares
Form 144 ↗
Dec 19, 2025William Waddill
Director
ARWR
Arrowhead Pharmaceuticals, Inc.
8,367$566.0K10b5-1Dec 19, 2025Form 4 ↗
4 days later · 8,367 shares
Form 144 ↗
Dec 19, 2025Adeoye Olukotun
Director
ARWR
Arrowhead Pharmaceuticals, Inc.
10,000$676.6K10b5-1Dec 19, 2025Form 4 ↗
4 days later · 10,000 shares
Form 144 ↗
Dec 19, 2025Victoria Vakiener
Director
ARWR
Arrowhead Pharmaceuticals, Inc.
10,040$679.5K10b5-1Dec 19, 2025Form 4 ↗
4 days later · 10,040 shares
Form 144 ↗
Dec 17, 2025Christopher Anzalone
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
85,000$5.4M—Dec 17, 2025Form 4 ↗
2 days later · 85,000 shares
Form 144 ↗
Dec 16, 2025Christopher Anzalone
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
54,298$3.4M—Dec 16, 2025Form 4 ↗
same day · 184,298 shares
Form 144 ↗
Dec 15, 2025Christopher Anzalone
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
130,000$9.0M—Dec 15, 2025Form 4 ↗
1 day later · 184,298 shares
Form 144 ↗
Dec 5, 2025Michael Perry
Director
ARWR
Arrowhead Pharmaceuticals, Inc.
16,250$991.1K—Dec 5, 2025Form 4 ↗
4 days later · 16,250 shares
Form 144 ↗
Nov 28, 2025Mauro Ferrari
Director
ARWR
Arrowhead Pharmaceuticals, Inc.
8,750$493.1K—Nov 28, 2025Form 4 ↗
3 days later · 8,750 shares
Form 144 ↗
Oct 1, 2025James Hamilton
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
20,000$700.0K10b5-1Oct 1, 2025Form 4 ↗
2 days later · 20,000 shares
Form 144 ↗
Sep 12, 2025James C. Hamilton
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
15,000$450.0K10b5-1Sep 12, 2025Form 4 ↗
4 days later · 15,000 shares
Form 144 ↗
Sep 2, 2025James C. Hamilton
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
15,000$375.0K10b5-1Sep 2, 2025Form 4 ↗
2 days later · 15,000 shares
Form 144 ↗
Aug 15, 2025James C. Hamilton
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
9,389$187.8K10b5-1Aug 15, 2025Form 4 ↗
same day · 10,000 shares
Form 144 ↗
Aug 13, 2025James C. Hamilton
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
611$12.2K10b5-1Aug 13, 2025Form 4 ↗
2 days later · 10,000 shares
Form 144 ↗
Aug 13, 2025Sarepta Therapeutics, Inc.
Shareholder
ARWR
Arrowhead Pharmaceuticals, Inc.
9.27M$185.2M—Aug 13, 2025—Form 144 ↗
Jul 10, 2025Myszkowski Kenneth Allen
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
40,000$761.7K—Jul 10, 2025—Form 144 ↗
Apr 11, 2025Christopher Richard Anzalone
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
50,800$583.8K—Apr 11, 2025Form 4 ↗
same day · 141,122 shares
Form 144 ↗
Apr 10, 2025Christopher Richard Anzalone
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
50,000$543.2K—Apr 10, 2025Form 4 ↗
1 day later · 141,122 shares
Form 144 ↗
Apr 9, 2025Christopher Richard Anzalone
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
40,322$406.1K—Apr 9, 2025Form 4 ↗
2 days later · 141,122 shares
Form 144 ↗
Mar 13, 2025Christopher Richard Anzalone
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
51,425$774.8K—Mar 13, 2025Form 4 ↗
4 days later · 51,425 shares
Form 144 ↗
Mar 4, 2025Christopher Richard Anzalone
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
133,333$2.3M10b5-1Mar 4, 2025Form 4 ↗
1 day later · 300,000 shares
Form 144 ↗
Mar 3, 2025Christopher Richard Anzalone
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
166,667$3.0M10b5-1Mar 3, 2025Form 4 ↗
2 days later · 300,000 shares
Form 144 ↗
Jan 23, 2025Adeoye Y. Olukotun
Director
ARWR
Arrowhead Pharmaceuticals, Inc.
959$20.1K10b5-1Jan 23, 2025Form 4 ↗
4 days later · 959 shares
Form 144 ↗
Jan 7, 2025Myszkowski Kenneth Allen
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
10,000$196.9K—Jan 7, 2025Form 4 ↗
same day · 45,167 shares
Form 144 ↗
Jan 7, 2025Myszkowski Kenneth Allen
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
8,000$157.5K10b5-1Jan 7, 2025Form 4 ↗
same day · 45,167 shares
Form 144 ↗
Jan 7, 2025Patrick O'Brien
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
8,000$157.5K10b5-1Jan 7, 2025Form 4 ↗
same day · 37,184 shares
Form 144 ↗
Jan 6, 2025Myszkowski Kenneth Allen
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
5,817$115.3K10b5-1Jan 6, 2025Form 4 ↗
1 day later · 45,167 shares
Form 144 ↗
Jan 6, 2025Myszkowski Kenneth Allen
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
9,255$183.5K10b5-1Jan 6, 2025Form 4 ↗
1 day later · 45,167 shares
Form 144 ↗
Jan 6, 2025Myszkowski Kenneth Allen
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
6,287$124.5K10b5-1Jan 6, 2025Form 4 ↗
1 day later · 45,167 shares
Form 144 ↗
Jan 6, 2025Myszkowski Kenneth Allen
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
5,817$115.3K10b5-1Jan 6, 2025Form 4 ↗
1 day later · 45,167 shares
Form 144 ↗
Jan 6, 2025James C. Hamilton
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
32,729$648.7K10b5-1Jan 6, 2025Form 4 ↗
1 day later · 32,729 shares
Form 144 ↗
Jan 6, 2025Patrick O'Brien
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
29,184$578.5K10b5-1Jan 6, 2025Form 4 ↗
1 day later · 37,184 shares
Form 144 ↗
Jan 2, 2025Christopher Richard Anzalone
Officer
ARWR
Arrowhead Pharmaceuticals, Inc.
11,520$219.4K10b5-1Jan 2, 2025Form 4 ↗
4 days later · 11,520 shares
Form 144 ↗
Dec 27, 2024Adeoye Y. Olukotun
Director
ARWR
Arrowhead Pharmaceuticals, Inc.
2,850$57.0K10b5-1Dec 27, 2024Form 4 ↗
3 days later · 2,850 shares
Form 144 ↗

The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 7:20 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances